Tilray Inc (NASDAQ:TLRY - Get Free Report)'s stock price dropped 0.3% during mid-day trading on Tuesday . The stock traded as low as $1.71 and last traded at $1.73. Approximately 9,844,903 shares were traded during mid-day trading, a decline of 61% from the average daily volume of 25,113,730 shares. The stock had previously closed at $1.73.
Wall Street Analyst Weigh In
Separately, Roth Mkm reduced their price objective on Tilray from $2.00 to $1.75 and set a "neutral" rating for the company in a research note on Friday, October 11th.
Get Our Latest Stock Report on Tilray
Tilray Stock Performance
The firm has a 50-day moving average of $1.69 and a two-hundred day moving average of $1.79. The company has a quick ratio of 1.57, a current ratio of 2.47 and a debt-to-equity ratio of 0.08. The company has a market capitalization of $1.60 billion, a PE ratio of -6.56 and a beta of 2.14.
Tilray (NASDAQ:TLRY - Get Free Report) last announced its quarterly earnings results on Thursday, October 10th. The company reported ($0.04) earnings per share for the quarter, meeting the consensus estimate of ($0.04). The company had revenue of $200.00 million during the quarter, compared to analysts' expectations of $218.70 million. Tilray had a negative return on equity of 2.00% and a negative net margin of 26.79%. Tilray's quarterly revenue was up 13.0% on a year-over-year basis. During the same period last year, the business earned ($0.10) earnings per share. Research analysts anticipate that Tilray Inc will post -0.14 EPS for the current year.
Institutional Trading of Tilray
Several institutional investors have recently bought and sold shares of TLRY. Prospect Financial Services LLC acquired a new stake in Tilray in the second quarter valued at approximately $26,000. Signature Estate & Investment Advisors LLC acquired a new stake in Tilray in the second quarter valued at approximately $29,000. Jeppson Wealth Management LLC acquired a new stake in shares of Tilray in the second quarter worth approximately $33,000. Vanguard Capital Wealth Advisors acquired a new stake in shares of Tilray in the second quarter worth approximately $34,000. Finally, HBK Sorce Advisory LLC acquired a new stake in shares of Tilray in the first quarter worth approximately $37,000. 9.35% of the stock is owned by institutional investors and hedge funds.
Tilray Company Profile
(
Get Free Report)
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.
Recommended Stories
Before you consider Tilray, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tilray wasn't on the list.
While Tilray currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
